Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Revolutions Medical Corporation announces that recent mass media reports that CT scans cause cancer could rapidly elevate MRI as the technology of choice for musculoskeletal scans.

Revolutions Medical Corporation, producers of the RevVac safety syringe, RevColor, RevDisplay and Rev3D MRI Technology, announced that recent mass media reports that CT scans cause cancer could rapidly elevate MRI as the technology of choice for musculoskeletal scans and more. A resulting spike in the number of MRI scans would not be met by an equal increase in the number of radiologists, making the need to arm the existing ranks with enhanced diagnostic tools a critical one.

According to the Archives of Internal Medicine, radiation from CT scans done in 2007 alone will cause 29,000 cancers (including 2,000 excess breast cancer cases) and kill nearly 15,000 Americans.

"MRI has long been a potential replacement for CT scans across a variety of applications, but CT has been the physicians' choice as the less expensive of the two options. With the very real dangers of CT now exposed, patient safety will likely trump cost concerns. Moreover, as insurance companies evaluate the financial impact of a cancer case vs. a moderately more expensive scan, the math may drive a mandated move to MRI.

evMed's products include the RevVac safety syringe (FDA approved), safety blood drawing device and safety IV catheter. RevMed also provides RevColor, RevDisplay and Rev3D -- software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software suite's functionality includes sorting of images, color, 3D and automatic segmentation of images.

Source: Revolutions Medical Corporation

You can discuss more about CT and related topics in our CT Group.